Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. [electronic resource]
- Pediatric blood & cancer Feb 2012
- 221-5 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1545-5017
10.1002/pbc.23130 doi
Adolescent Antibodies, Monoclonal, Murine-Derived--therapeutic use Antineoplastic Agents--therapeutic use Child Child, Preschool Chronic Disease Cohort Studies Female Follow-Up Studies Glucocorticoids--therapeutic use Humans Immunoglobulins, Intravenous--therapeutic use Immunologic Factors--therapeutic use Infant Infant, Newborn Longitudinal Studies Male Platelet Count Prednisone--therapeutic use Prospective Studies Retrospective Studies Rituximab Thrombocytopenia--drug therapy Treatment Outcome